Vifor Pharma (GNHAY) Stock Price, News & Analysis

Company Overview

Vifor Pharma was a Switzerland-based pharmaceutical company focused on treatments for iron deficiency, anemia, and related conditions in nephrology, dialysis, and cardio-renal care. Its products included intravenous and oral iron therapies, treatments for hyperphosphatemia in patients with chronic kidney disease, and medicines used in other specialty-care settings.

The company’s portfolio included Ferinject, marketed as Injectafer in the United States, Venofer, and Velphoro. Vifor Pharma served healthcare providers and patients across Europe, North America, and other international markets through commercial operations and partnerships.

Vifor Pharma developed from the pharmaceutical activities of Swiss healthcare group Galenica and became an independently listed company in 2017. CSL Limited completed its acquisition of Vifor Pharma in 2022, after which the business was integrated into CSL’s specialty pharmaceutical operations and rebranded as CSL Vifor.

Key Stats

• Today's Range: $38.39 to $38.39
• 50-Day Range: $38.39 to $38.39
• 52-Week Range: $31.18 to $38.39
• Volume: N/A
• Average Volume: 7,364 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:GNHAY
• CIK: N/A
• Web: www.viforpharma.com
• Phone: (158) 851-8000
• Fax: N/A
• Employees: 2,200
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A